VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Technology Scientific & Technical Instruments

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Post by Sonny7on Mar 05, 2019 1:28am

244 Views

Post# 29441893

Is it Good News?

Is it good news?....... Does a cat have climbing gear??

Food for Thought, below, from the news release. $58-billion in 2017? If Ventripoint picks up 1% of that for medical devices spending with their number of shares issued, can we calculate the potential value of VPT shares?
That is for China alone......

*Marketing efforts are well under way in the Chinese market with the creation of a multichannel distribution network. The medical device market in China was estimated at over $58-billion (U.S.) in 2017 and experienced 20-per-cent growth from 2015 to 2016. There are over 2,500 tier 1 hospitals and a total of 32,000 hospitals, with over 1,000 new hospitals currently under construction.*

Bullboard Posts

The top 10 Canadian medical stocks